These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 17122900)

  • 21. Medications for substance use disorders.
    Douaihy AB; Kelly TM; Sullivan C
    Soc Work Public Health; 2013; 28(3-4):264-78. PubMed ID: 23731419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy for alcohol dependence: status of current treatments.
    Franck J; Jayaram-Lindström N
    Curr Opin Neurobiol; 2013 Aug; 23(4):692-9. PubMed ID: 23810221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New drugs in the treatment of alcoholism].
    Besson J
    Schweiz Med Wochenschr; 1997 Sep; 127(38):1574-8. PubMed ID: 9411716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
    Wilde MI; Wagstaff AJ
    Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acamprosate campral for alcoholism.
    Med Lett Drugs Ther; 2005 Jan; 47(1199):1-3. PubMed ID: 15599336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging approaches to managing alcohol dependence.
    Swift R
    Am J Health Syst Pharm; 2007 Mar; 64(5 Suppl 3):S12-22. PubMed ID: 17322178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic approaches to the management of alcoholism.
    Anton RF
    J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.
    Zarkin GA; Bray JW; Aldridge A; Mitra D; Mills MJ; Couper DJ; Cisler RA;
    Arch Gen Psychiatry; 2008 Oct; 65(10):1214-21. PubMed ID: 18838638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurobiological mechanisms and pharmacological treatment options for alcohol craving].
    Hillemacher T; Kornhuber J; Bleich S
    Fortschr Neurol Psychiatr; 2007 Jan; 75(1):26-32. PubMed ID: 17031777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alcoholic patients' experience and attitudes on pharmacotherapy for alcoholism.
    Swift RM; Duncan D; Nirenberg T; Femino J
    J Addict Dis; 1998; 17(3):35-47. PubMed ID: 9789158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical and clinical pharmacology of alcohol dependence.
    Tambour S; Quertemont E
    Fundam Clin Pharmacol; 2007 Feb; 21(1):9-28. PubMed ID: 17227441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.
    Diehl A; Ulmer L; Mutschler J; Herre H; Krumm B; Croissant B; Mann K; Kiefer F
    Alcohol Alcohol; 2010; 45(3):271-7. PubMed ID: 20348436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.
    Scott LJ; Figgitt DP; Keam SJ; Waugh J
    CNS Drugs; 2005; 19(5):445-64. PubMed ID: 15907154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent developments in the pharmacotherapy of alcohol dependence.
    Schuckit MA
    J Consult Clin Psychol; 1996 Aug; 64(4):669-76. PubMed ID: 8803356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New pharmacological approaches for the treatment of alcoholism.
    Soyka M; Roesner S
    Expert Opin Pharmacother; 2006 Dec; 7(17):2341-53. PubMed ID: 17109610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.
    Kenna GA; McGeary JE; Swift RM
    Am J Health Syst Pharm; 2004 Nov; 61(21):2272-9. PubMed ID: 15552634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
    Buri C; Moggi F; Giovanoli A; Strik W
    Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings.
    Litten RZ; Allen JP
    J Subst Abuse Treat; 1999 Mar; 16(2):105-12. PubMed ID: 10023607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical pharmacology of acamprosate.
    Kalk NJ; Lingford-Hughes AR
    Br J Clin Pharmacol; 2014 Feb; 77(2):315-23. PubMed ID: 23278595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.